By 2020 , Preimplantation Genetic Diagnosis Market To Grow at a CAGR of 6.28%

Global Preimplantation Genetic Diagnosis Market to Reach US$118.0 million by 2020 due to
Rising Infertility
Transparency Market Research (TMR) has announced the publication of a new market research
report on the preimplantation genetic diagnosis. Statistics mentioned in the report suggest that the
global preimplantation genetic diagnosis market was valued at US$77.2 million in 2013 and is
expected to reach US$118.0 million by 2020, growing a CAGR of 6.28% from 2014 to 2020. The
report, titled “Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast, 2014 - 2020”, offers an in-depth understanding of the global
preimplantation genetic diagnosis market, its growth drivers, market restraints, and potential growth
opportunities in the coming future.
Report overview @ https://www.transparencymarketresearch.com/preimplantation-geneticdiagnosis-market.html
The global Preimplantation Genetic Diagnosis Market is segmented on the basis of Test
Type,Geography.
The global preimplantation genetic diagnosis market has been differentiated based on the types of
tests and geographies. Based on the types of tests, the global preimplantation genetic diagnosis
market has been segmented into six categories: PGD for chromosomal aberrations, aneuploidy
screening, X-linked diseases, single gene disorder, HLA typing and gender selection. A detailed
market analysis of the segments mentioned above has been provided at the global level in this study.
The market analysis is based on market size and forecast in terms of USD million for the period
2013 to 2020 along with the compounded annual growth rate (CAGR %) for the period 2014 to
2020, considering 2013 as the base year.
Geographically, the global preimplantation genetic diagnosis market has been categorized into four
regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section further
provides market size and forecast for various types of PFD tests in each region. The market size and
forecast of the regional markets is provided for the period 2012 to 2020. CAGR (%) for each region
is also estimated for the period 2014 to 2020, considering 2013 as the base year. The report also
includes strategic recommendations, which would help market players sustain and grow in the
highly competitive market. These recommendations would also help new entrants establish a strong
position in the global preimplantation genetic diagnosis market.
Request A Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=427
Summary of Table of Content
1.
2.
3.
4.
5.
6.
7.
Introduction
Executive Summary
Global Preimplantation Genetic Diagnosis Market Overview
Global Preimplantation Genetic Diagnosis Market, by Test Type
Preimplantation Genetic Diagnosis Market, by Geography
Recommendations
Company Profiles
Get Full Report @ https://www.transparencymarketresearch.com/checkout.php?
rep_id=427&ltype=S
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business
information reports and services. The company’s exclusive blend of quantitative forecasting and
trend analysis provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary data sources and various
tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it
always reflects the latest trends and information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Sales: [email protected]
Website: www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/

Preimplantation genetic diagnosis (PGD) is an adjuvant technique to in vitro fertilization (IVF) for detecting genetic diseases or conditions before the implantation of embryo. PGD can be performed for screening of a range of medical conditions such as Down’s syndrome, inheritable diseases and traits of other physiological abnormality. Increasing patient awareness about PGD technique and rising prevalence of genetic disorders among infants has led to the rise in demand for PGD along with IVF procedure. The combination of PGD and IVF has improved the rate of successful pregnancy due to reduced chances of passing the undesired genetic material in the embryo.

Download Report